This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

KYTHERA Biopharmaceuticals Inc (KYTH)

: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 29.23M 111.52M 79.31M 34.58M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 101.16M 173.28M 87.59M 44.33M
Property, Plant & Equipment, Gross 3.16M 1.36M 1.32M 1.13M
Accumulated Depreciation & Depletion 1.32M 1.27M 1.04M 408.00K
Property, Plant & Equipment, Net 1.85M 94.00K 275.00K 720.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 420.00K 37.00K 8.36M 31.00K
Total Non-Current Assets 2.27M 131.00K 8.63M 751.00K
Liabilities & Shareholder Equity
Total Assets 103.43M 173.41M 96.22M 45.08M
Accounts Payable 4.69M 3.23M 2.15M 962.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 637.00K 0.00 0.00 4.95M
Total Current Liabilities 20.63M 17.58M 16.22M 14.80M
Long Term Debt 22.66M 5.98M 2.76M 0.00
Deferred Income Taxes 0.00 8.00K 9.00K 7.00K
Other Non-Current Liabilities 698.00K 0.00 8.32M 3.70M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 23.36M 5.99M 11.09M 111.30M
Total Liabilities 43.99M 23.57M 27.32M 126.10M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 59.44M 149.84M 68.91M -81.02M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 367.33M 322.05M 189.21M 2.48M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -307.84M -172.22M -120.31M -83.51M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -53.00K 4.00K 0.00 0.00
Total Capitalization 82.10M 155.82M 71.67M -81.02M
Total Equity 59.44M 149.84M 68.91M -81.02M
Total Liabilities & Stock Equity 103.43M 173.41M 96.22M 45.08M
Total Common Shares Outstanding 22.69M 21.74M 18.32M 17.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 22.47M 19.15M 14.06M 11.15M
Diluted Weighted Shares Outstanding 22.47M 19.15M 14.06M 11.15M
Number of Employees 106 64 46 NA
Number of Part-Time Employees 0 0 0 NA

KYTH KYTHERA Biopharmaceuticals Inc

Chart of KYTH

Analysts Ratings for KYTH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

KYTH Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs